Vascular Access Device Market Global Forecasts to 2022

Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users

(EMAILWIRE.COM, May 10, 2019 ) Vascular access devices include central vascular access devices, peripheral vascular access devices, and accessories.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122149686

The global vascular access device market is projected to grow from USD 3.87 Billion in 2017 to reach to USD 5.45 Billion by 2022 at a CAGR of 7.1%. Base year considered for the report is 2016.

The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.

The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices.

Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=122149686

The major players in this market include Major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C.R.Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B.Braun Melsungen Ag (Germany), Angiodynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodi med (France).